dc.contributor.author | Regueiro, Cristina | |
dc.contributor.author | Rodríguez-Martínez, Lorena | |
dc.contributor.author | Nuño, Laura | |
dc.contributor.author | Ortiz, Ana M. | |
dc.contributor.author | Villaba, Alejandro | |
dc.contributor.author | Pascual-Salcedo, Dora | |
dc.contributor.author | Martínez-Feito, Ana | |
dc.contributor.author | González-Alvaro, Isidoro | |
dc.contributor.author | Balsa Criado, Alejandro | |
dc.contributor.author | González, Antonio | |
dc.contributor.other | UAM. Departamento de Medicina | es_ES |
dc.contributor.other | Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ) | es_ES |
dc.date.accessioned | 2020-06-30T06:15:38Z | |
dc.date.available | 2020-06-30T06:15:38Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Arthritis Research & Therapy 21 (2019): 280 | en_US |
dc.identifier.issn | 1478-6354 (print) | es_ES |
dc.identifier.issn | 1478-6362 (online) | es_ES |
dc.identifier.uri | http://hdl.handle.net/10486/691475 | |
dc.description.abstract | Background: The patients with RA benefit from early identification soon after the first clinical symptoms appear.
The 2010 ACR/EULAR classification criteria were developed to fulfill this need and their application has been
demonstrated to be effective. However, there is still room for improvement. Therefore, we aimed to evaluate the
potential of the concordant presence of RF, anti-CCP and anti-carbamylated protein antibodies to improve current
RA classification among early arthritis (EA) patients.
Methods: Data from the first visit of 1057 patients in two EA prospective cohorts were used. The serological scores
from the 2010 ACR/EULAR criteria and the concordant presence of the three RA autoantibodies were assessed
relative to a gold standard consisting of the RA classification with the 1987 ACR criteria at the 2 years of follow-up.
Results: The concordant presence of three antibodies showed predictive characteristics allowing for direct
classification as RA (positive predictive value = 96.1% and OR = 80.9). They were significantly better than the
corresponding to the high antibody titers defined as in the 2010 classification criteria (PPV = 88.8%, OR = 26.1). In
addition, the concordant presence of two antibodies was also very informative (PPV = 82.3%, OR = 15.1). These
results allowed devising a scoring system based only on antibody concordance that displayed similar overall
performance as the serological scoring system of the 2010 criteria. However, the best classification was obtained
combining the concordance and 2010 serological systems, a combination with a significant contribution from each
of the two systems.
Discussion: The concordant presence of RA autoantibodies showed an independent contribution to the
classification of EA patients that permitted increased discrimination and precision. | en_US |
dc.description.sponsorship | This work was supported by the Instituto de Salud Carlos III (Spain) through
grants [PI17/01606 and RD16/0012/0014 to AG; RD16/0012/0011 to IG-A and
RD16/0012/0012 to AB]. These grants are partially financed by the European
Regional Development Fund of the EU (FEDER). CR was supported by Ministerio
de Educacion Cultura y Deporte (Spain) through a FPU pre-doctoral fellowship
[FPU15/03434]. LR-M was supported by a Xunta de Galicia
predoctoral contract. | en_US |
dc.format.extent | 7 pag. | es_ES |
dc.format.mimetype | application/pdf | en |
dc.language.iso | eng | en |
dc.publisher | BMC (part of Springer Nature) | en_US |
dc.relation.ispartof | Arthritis Research & Therapy | en_US |
dc.rights | © The Author(s). 2019 | en_US |
dc.subject.other | Rheumatoid arthritis | en_US |
dc.subject.other | Early arthritis | en_US |
dc.subject.other | Disease classification | en_US |
dc.subject.other | Autoantibodies | en_US |
dc.subject.other | Rheumatoid factor | en_US |
dc.subject.other | Anticitrullinated protein antibodies | en_US |
dc.subject.other | Anti-carbamylated protein antibodies | en_US |
dc.title | Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: Analysis in two early arthritis clinics | en_US |
dc.type | article | en |
dc.subject.eciencia | Medicina | es_ES |
dc.relation.publisherversion | https://doi.org/10.1186/s13075-019-2079-4 | es_ES |
dc.identifier.doi | 10.1186/s13075-019-2079-4 | es_ES |
dc.identifier.publicationfirstpage | 280-1 | es_ES |
dc.identifier.publicationissue | 21 | es_ES |
dc.identifier.publicationlastpage | 280-7 | es_ES |
dc.relation.projectID | Gobierno de España. RD16/0012/0012 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | en |
dc.rights.cc | Reconocimiento | es_ES |
dc.rights.accessRights | openAccess | en |
dc.authorUAM | Balsa Criado, Alejandro (259517) | |
dc.facultadUAM | Facultad de Medicina | |
dc.institutoUAM | Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ) | |